Physician profile
Robert Singer
NPI 1518027911
$2,373.86
in general payments reported to CMS, 2019-2025
14 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.69 · 2020: $45.61 · 2021: $742 · 2022: $105 · 2023: $414 · 2024: $641 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $582.16 | 2021 | |
| Abbvie INC. | $397.06 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Motiva USA, LLC | $320.66 | 2024-2025 | |
| Mentor Worldwide LLC | $311.01 | 2023-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $261.27 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $105.95 | 2024 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $103.38 | 2025 | |
| Galderma Laboratories, L.P. | $80.49 | 2019-2020 | |
| Integra Lifesciences Corporation | $76.58 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Allergan, INC. | $60.63 | 2021-2022 | |
| Innovation Technologies INC | $24.26 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.24 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $14.81 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.